Header Logo

Connection

SRDAN VERSTOVSEK to Killer Cells, Natural

Back to Details
This is a "connection" page, showing publications SRDAN VERSTOVSEK has written about Killer Cells, Natural.
SRDAN VERSTOVSEK
Connection Strength
0.012
Killer Cells, Natural
  1. Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2006 Sep 01; 12(17):5165-73.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.